Average Insider

Where insiders trade, we follow

BridgeBio Pharma, Inc. ($BBIO)
Accession: 0001470831-26-000472
May 19, 2026
๐Ÿ“ˆ Chart on TradingView๐Ÿ’ฐ Financials on Finviz
52W Low$42.09
Current$79.9673.8% above low, 26.2% below high
52W High$93.42

Filing Information

Accession Number0001470831-26-000472
Form Type4
Filing DateMay 19, 2026
DocumentView SEC Filing
Transactions
9
Total Shares
178,666
Total Value
$2,396,286.68

Transactions

NameTitleSecurityDerivativeTransaction DateTypeSharesPriceTotal CostShares AfterDirect/IndirectNature of OwnershipActions
Kumar Neil
Director
Common Stock
โ€”May 16, 2026Exercise/Conversion33,544โ€”โ€”267,995Directโ€”View Details
Kumar Neil
Director
Common Stock
โ€”May 16, 2026Exercise/Conversion19,599โ€”โ€”287,594Directโ€”View Details
Kumar Neil
Director
Common Stock
โ€”May 16, 2026Exercise/Conversion11,553โ€”โ€”299,147Directโ€”View Details
Kumar Neil
Director
Common Stock
โ€”May 16, 2026Exercise/Conversion6,519โ€”โ€”305,666Directโ€”View Details
Kumar Neil
Director
Common Stock
โ€”May 16, 2026Tax Withholding36,236$66.13$2,396,286.68269,430Directโ€”View Details
Kumar Neil
Director
Restricted Stock Units
(Common Stock)
DerivativeMay 16, 2026Exercise/Conversion33,544$0.00$0.00100,632Directโ€”View Details
Kumar Neil
Director
Restricted Stock Units
(Common Stock)
DerivativeMay 16, 2026Exercise/Conversion19,599$0.00$0.00137,195Directโ€”View Details
Kumar Neil
Director
Restricted Stock Units
(Common Stock)
DerivativeMay 16, 2026Exercise/Conversion11,553$0.00$0.00127,092Directโ€”View Details
Kumar Neil
Director
Restricted Stock Units
(Common Stock)
DerivativeMay 16, 2026Exercise/Conversion6,519$0.00$0.0097,794Directโ€”View Details
Version: v26.7.3